Legal Advisers
Eli Lilly was advised on the transaction by Paul Weiss Rifkind Wharton & Garrison LLP. The advisory team included partners Krishna Veeraraghavan, Chelsea Darnell and Jeffrey D. Osterman.
Full details regarding the Goodwin Procter LLP legal team representing Orna were not immediately available Monday.
As the deal advances, regulatory and clinical milestones will determine whether this high-stakes partnership delivers on its promise — a reminder that in biotechnology, as in exploration, the boldest steps often carry both risk and transformative potential.
